Washington, DC - Chairman Marsha Blackburn has sent a letter to Cate Dyer, CEO of StemExpress, requesting full cooperation with the Select Investigative Panel ’s efforts to obtain all business and accounting documents from the fetal tissue procurement organization.
“Over the last several months, we have made numerous attempts to acquire business and accounting documents from StemExpress that are necessary to complete our work at the Select Investigative Panel," Blackburn wrote in the letter. “All of these requests have been met with verbal and written objections from your attorneys. In light of recent public comments you have made and the consensus reached by witnesses at our April 20 hearing on The Pricing of Fetal Tissue that a complete review of StemExpress business and accounting documents was necessary, I am writing to personally request you turn this information over to our investigators."
